2019
DOI: 10.1002/jia2.25385
|View full text |Cite
|
Sign up to set email alerts
|

Long‐term retention in pre‐exposure prophylaxis care among men who have sex with men and transgender women in the United States

Abstract: Introduction Retention in HIV pre‐exposure prophylaxis (PrEP) care in real‐world settings, outside of controlled trials or demonstration projects, remains poorly understood. Methods We evaluated retention in PrEP care outcomes among men who have sex with men (MSM) and transgender women prescribed PrEP through March 2017 at three clinical sites in the United States (US): Jackson, Mississippi; Providence, Rhode Island; and St. Louis, Missouri. We determined retention rate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
35
2

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 46 publications
(42 citation statements)
references
References 37 publications
5
35
2
Order By: Relevance
“…Nevertheless, overall discontinuation rates in our study were comparatively low: other demonstration projects found similar rates over much shorter follow-up time [ 20 , 27 , 28 ] and higher discontinuation rates were observed in larger-scale clinical or primary care implementation settings [ 13 , 29 ]. As our project is one of the few offering a choice of PrEP regimens, PrEP discontinuation might be low when having access to an alternative, non-daily regimen.…”
Section: Discussioncontrasting
confidence: 52%
See 1 more Smart Citation
“…Nevertheless, overall discontinuation rates in our study were comparatively low: other demonstration projects found similar rates over much shorter follow-up time [ 20 , 27 , 28 ] and higher discontinuation rates were observed in larger-scale clinical or primary care implementation settings [ 13 , 29 ]. As our project is one of the few offering a choice of PrEP regimens, PrEP discontinuation might be low when having access to an alternative, non-daily regimen.…”
Section: Discussioncontrasting
confidence: 52%
“…Despite its importance, long-term retention rates and characteristics of those who are not retained are understudied in real-life settings. The few studies addressing retention have shown that those who discontinue PrEP or are not retained in PrEP care are usually younger [ 12 , 13 ] and have a decreased perceived risk of HIV [ 12 , 14 ]. However, median follow-up time was generally one year or shorter in these studies.…”
Section: Introductionmentioning
confidence: 99%
“…However, many individuals may need ongoing support beyond the first several months of PrEP use to ensure sustained use throughout periods of HIV risk. 12 , 13 , 45 An analysis of administrative pharmacy records by Coy et al 13 found that nearly two-thirds of all PrEP users at a national chain pharmacy had discontinued PrEP by the second year. Our results are consistent with those findings.…”
Section: Discussionmentioning
confidence: 99%
“…Although several studies have evaluated the PrEP continuum in real-world settings, existing data have largely relied on small patient samples or administrative insurance databases with incomplete clinical information. 9 , 10 , 11 , 12 , 13 , 14 , 15 Comprehensive long-term follow-up data are needed to accurately evaluate PrEP continuum outcomes and identify individuals most at risk for falling out of care and acquiring HIV.…”
Section: Introductionmentioning
confidence: 99%
“…Current practice guidelines suggest that GBM follow up with their medical provider every 3 months while they are on PrEP for HIV and sexually transmitted infection (STI) testing and kidney function monitoring, among other things [ 19 ], but in practice, patients using PrEP often follow up less frequently [ 20 , 21 ]. Similarly, practice guidelines recommend providing adherence counseling to all patients using PrEP [ 19 ], but it is not clear how many patients using PrEP actually receive some form of counseling.…”
Section: Introductionmentioning
confidence: 99%